Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from OncoCyte

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022

Expert Ratings for OncoCyte

Expert Ratings for OncoCyte

Within the last quarter, OncoCyte (NASDAQ:OCX) has observed the following analyst ratings:

OncoCyte: Q1 Earnings Insights

OncoCyte: Q1 Earnings Insights

OncoCyte (NASDAQ:OCX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings OncoCyte reported in-line EPS of $-0.12 versus an estimate of $-0.12.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

2 Stocks Under $2 Insiders Are Aggressively Buying

Gold futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading…

4 Stocks Under $5 Insiders Are Aggressively Buying

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading…

What 4 Analyst Ratings Have To Say About OncoCyte

OncoCyte (NASDAQ:OCX) has observed the following analyst ratings within the last quarter:

1

Organisations

Prudential Financial

Travelers Companies

Lattice Semiconductor

Reinsurance Group

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

375,838 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play